- Home
- NBIS
NBIS
NEBIUS GROUP N V
as 06-09-2025 4:00pm EST
Stocks
Nebius Group NV is a tech company. It is a European provider of infrastructure and services to AI builders globally. The group builds full-stack infrastructure to service the growth of the AI industry, including the scale of GPU clusters, cloud platforms, tools, and services for developers. It has R&D hubs across Europe, North America and Israel.
| Founded: | 2000 | Country: | Netherlands |
| Employees: | N/A | City: | N/A |
| Market Cap: | 4.8B | IPO Year: | 2011 |
| Target Price: | $52.33 | AVG Volume (30 days): | 17.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.84 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.09 - $55.04 | Next Earning Date: | 07-30-2025 |
| Revenue: | $161,400,000 | Revenue Growth: | -98.14% |
| Revenue Growth (this year): | 36445.53% | Revenue Growth (next year): | N/A |
Latest NEBIUS GROUP N V News
NBIS Breaking Stock News: Dive into NBIS Ticker-Specific Updates for Smart Investing
TipRanks
3 days ago
Salesforce initiated, Dollar Tree upgraded: Wall Street’s top analyst calls
TipRanks
3 days ago
Arete initiates CoreWeave and Nebius with preference for Nebius
Insider Monkey
4 days ago
Why Nebius Group N.V. (NBIS) Soared On Thursday
Yahoo Finance Video
4 days ago
Dollar Tree, Nebius, Palantir: Trending Tickers
Business Wire
8 days ago
Nebius Group announces private placement of $1 billion in aggregate principal amount of convertible notes
TipRanks
9 days ago
Diversification Strategy Sparks Bullish Impetus in Nebius Group Stock (NBIS)
Business Wire
10 days ago
Nebius participates in ClickHouse Series C; crystallizes value of asset to fund hypergrowth of core AI infrastructure business
Yahoo Finance Video
12 days ago
Nvidia earnings: Its AI performance could lift these stocks
Compare NBIS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NBIS NEBIUS GROUP N V - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.